Capability
Service linesRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · MEDICAL LABORATORIES · TESTING LABORATORIES AND SERVICES
Work mix: 58% prime · 42% sub · primary NAICS 621511 / PSC Q301 REFERENCE LABORATORY TESTING
Where they win
3 agenciesMostly sole-source · 110%
110% of Adaptive Biotechnologies’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
3 buyersRecompete exposure
LowLargely sole-source — these contracts typically renew with Adaptive Biotechnologies rather than being openly recompeted.
Adaptive Biotechnologies has $244K in contracts returning to market over the next 24 months. 1 within 6 months, $244K. As of Aug 19, 2026.
Dollars in this list are current contract value: base plus exercised options. The totals above add that same figure.
Adaptive Biotechnologies teams with
1Partners from federal subaward / teaming records (public).
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Adaptive Biotechnologies hold?
Adaptive Biotechnologies (UEI DMW5BNQ331K9) shows $843K across 24 awards in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K over 36 months through Aug 19, 2026.
How much in federal contracts does Adaptive Biotechnologies have?
Adaptive Biotechnologies shows $843K across 24 awards. SCOUT tracks 1 incumbent recompetes ($244K) returning to market in the next 24 months.
Which agencies does Adaptive Biotechnologies work with?
Adaptive Biotechnologies’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (47%), Department of Defense (DOD) (44%), Department of Veterans Affairs (VA) (9%).
What is the UEI for Adaptive Biotechnologies?
The Unique Entity ID (UEI) for Adaptive Biotechnologies is DMW5BNQ331K9.
Does Adaptive Biotechnologies have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
A row is the PIID, the date, and the current contract value.
SCOUT Durability is the read on that contract: six facts and the patterns they flag. Ten reads are the FY27 Sprint Pack, $2,800.
The Pack is ten Pursuit Analyses in a 12-month balance. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.